Prabhu S. Arunachalam,Madeleine K. D. Scott,Thomas Hagan,Chunfeng Li,Yupeng Feng,Florian Wimmers,Lilit Grigoryan,Meera Trisal,Venkata Viswanadh Edara,Lilin Lai,Sarah Esther Chang,Allan Feng,Shaurya Dhingra,Mihir Shah,Alexandra S. Lee,Sharon Chinthrajah,Sayantani B. Sindher,Vamsee Mallajosyula,Fei Gao,Natalia Sigal,Sangeeta Kowli,Sheena Gupta,Kathryn Pellegrini,Gregory Tharp,Sofia Maysel-Auslender,Sydney Hamilton,Hadj Aoued,Kevin Hrusovsky,Mark Roskey,Steven E. Bosinger,Holden T. Maecker,Scott D. Boyd,Mark M. Davis,Paul J. Utz,Mehul S. Suthar,Purvesh Khatri,Kari C. Nadeau,Bali Pulendran

Abstract:The emergency use authorization of two mRNA vaccines in less than a year since the emergence of SARS-CoV-2 represents a landmark in vaccinology1,2. Yet, how mRNA vaccines stimulate the immune system to elicit protective immune responses is unknown. Here we used a systems vaccinology approach to comprehensively profile the innate and adaptive immune responses of 56 healthy volunteers vaccinated with the Pfizer-BioNTech mRNA vaccine. Vaccination resulted in robust production of neutralizing antibodies (nAbs) against the parent Wuhan strain and, to a lesser extent, the B.1.351 strain, and significant increases in antigen-specific polyfunctional CD4 and CD8 T cells after the second dose. Booster vaccination stimulated a strikingly enhanced innate immune response compared to primary vaccination, evidenced by a greater: (i) frequency of CD14+CD16+ inflammatory monocytes; (ii) concentration of plasma IFN-g; (iii) transcriptional signature of innate antiviral immunity. Consistent with these observations, single-cell transcriptomics analysis demonstrated a ~100-fold increase in the frequency of a myeloid cell cluster, enriched in interferon-response transcription factors (TFs) and reduced in AP-1 TFs, following secondary immunization. Finally, we identified distinct innate pathways associated with CD8 T cell and nAb responses, and show that a monocyte-related signature correlates with the nAb response against the B.1.351 variant strain. Collectively, these data provide insights into immune responses induced by mRNA vaccination and demonstrate its capacity to prime the innate immune system to mount a more potent response following booster immunization.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand how mRNA vaccines (especially Pfizer–BioNTech's BNT162b2 vaccine) stimulate the immune system to produce a protective immune response. Specifically, through the method of systems vaccinology, the study comprehensively analyzed the innate and adaptive immune responses of 56 healthy volunteers after vaccination with BNT162b2 vaccine, aiming to reveal the following points: 1. **Antibody response**: Evaluate the levels of binding antibodies and neutralizing antibodies produced after vaccination, especially the changes after the primary vaccination and the booster vaccination. 2. **T - cell response**: Detect the vaccine - induced specific CD4 and CD8 T - cell responses against the spike protein of the novel coronavirus. 3. **Innate immune response**: Analyze the activation of the innate immune system after vaccination, including the increased frequency of inflammatory monocytes, the elevation of plasma IFNγ concentration, and the transcriptional characteristics of innate antiviral immunity. 4. **Age - related differences**: Explore whether there are differences in the immune responses to vaccination among individuals of different age groups. 5. **Autoantibodies and anti - cytokine antibodies**: Screen whether new autoantibodies or anti - cytokine antibodies will be produced after vaccination. 6. **Single - cell transcriptomics**: Through single - cell transcriptomics analysis, further analyze the transcriptional changes of immune cells after vaccination, especially the characteristics of newly emerging cell populations (such as C8 population) and their correlation with IFNγ levels. 7. **Comparison with other vaccines**: Compare the similarities and differences in the immune responses induced by BNT162b2 vaccine and other types of vaccines (such as inactivated vaccines, live - attenuated vaccines, etc.). Through these analyses, the study hopes to provide an in - depth understanding of how mRNA vaccines induce immune responses and provide a scientific basis for future vaccine design and optimization.

Systems vaccinology of the BNT162b2 mRNA vaccine in humans